Melinta Therapeutics, Llc
Clinical trials sponsored by Melinta Therapeutics, Llc, explained in plain language.
-
One-Shot antibiotic tested in kids for tough skin infections
Disease control CompletedThis study tested the safety of a single-dose antibiotic given by IV to children with serious bacterial skin infections. It involved 118 kids aged 3 months to under 12 years. Researchers compared two versions of the same drug to see how well they were tolerated and how they moved…
Phase: PHASE2 • Sponsor: Melinta Therapeutics, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
First test of One-Shot antibiotic for kids
Disease control CompletedThis early-stage study aimed to find a safe and effective single dose of the antibiotic oritavancin for children under 18 with serious bacterial infections. It tested how the drug moves through a child's body and monitored for side effects. The study started with older children a…
Phase: PHASE1 • Sponsor: Melinta Therapeutics, LLC • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC